<DOC>
	<DOCNO>NCT00082719</DOCNO>
	<brief_summary>RATIONALE : Interferon alfa may interfere growth tumor cell slow growth urothelial cancer . PURPOSE : This randomized phase I trial study well low-dose interferon alfa work treat patient cancer urothelium .</brief_summary>
	<brief_title>Short-Term Low-Dose Interferon Alfa Treating Patients With Cancer Urothelium</brief_title>
	<detailed_description>OBJECTIVES : - Determine modulation apoptosis-related pathway patient cancer urothelium treat short-term low-dose interferon alfa . OUTLINE : This randomize study . Patients randomize 1 4 treatment arm . In arm , treatment begin time pre-operative visit continue time cystoscopy . - Arm I : Patients receive low-dose interferon alfa subcutaneously ( SC ) twice daily . - Arm II : Patients receive interferon alfa arm I high dose . - Arm III : Patients receive interferon alfa SC daily . - Arm IV : Patients receive interferon alfa arm III high dose . In arm , treatment continue absence unacceptable toxicity . PROJECTED ACCRUAL : Approximately 30 patient accrue study .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Urethral Neoplasms</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>1 . Patients must histologically prove urothelial cancer , know suspect ( e.g . outside evaluation ) muscleinvasive , schedule cystoscopy transurethral biopsy part routine evaluation M. D. Anderson . 2 . Patients must understand investigational nature study provide write , informed consent . 1 . Patients pregnant lactate eligible . Women childbearing potential must negative pregnancy test start therapy . 2 . Patients current symptom suggestive clinically significant affective disorder . 3 . Patients take physiologic replacement dos corticosteroid eligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>stage II bladder cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>localize transitional cell cancer renal pelvis ureter</keyword>
	<keyword>regional transitional cell cancer renal pelvis ureter</keyword>
	<keyword>metastatic transitional cell cancer renal pelvis ureter</keyword>
	<keyword>anterior urethral cancer</keyword>
	<keyword>posterior urethral cancer</keyword>
	<keyword>urethral cancer associate invasive bladder cancer</keyword>
</DOC>